DOCS · Doximity, Inc. · Executive Compensation
$27.93
-0.57 (-2.00%)
At close · Oct 2
Return incl. dividend (before tax)
Market Cap
$5.05B
Shares
178.25M
Volume · Oct 2
2.67M
Avg daily vol (3M)
4.43M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2026
| Executive | Role | Total |
|---|---|---|
| Jeff Tangney | Chief Executive Officer | $19,586,169 |
| John T. Vaughan | General Counsel | $3,445,790 |
| Anna Bryson | Former Chief Financial Officer | $2,549,081 |
| Jennifer Chaloemtiarana | Former General Counsel | $1,778,065 |
| Sid Sitaram | Chief Accounting Officer | $917,680 |
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Jeff Tangney | Chief Executive Officer | $17,234,989 |
| Jennifer Chaloemtiarana | General Counsel | $1,651,869 |
| Nate Gross | Former Chief Strategy Officer | $1,520,444 |
| Anna Bryson | Chief Financial Officer | $825,394 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Craig Overpeck | SVP, Commercial Operations | $5,170,839 |
| Anna Bryson | Chief Financial Officer | $3,866,207 |
| Jennifer Chaloemtiarana | General Counsel | $603,941 |
| Nate Gross | Former Chief Strategy Officer | $305,469 |
| Jeff Tangney | Chief Executive Officer | $298,869 |
| Jeffrey A. Tangney | Chief Executive Officer | $298,869 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Nate Gross | Former Chief Strategy Officer | $1,804,686 |
| Jennifer Chaloemtiarana | General Counsel | $1,583,341 |
| Paul Jorgensen | Chief Revenue Officer | $455,135 |
| Anna Bryson | Chief Financial Officer | $453,709 |
| Jeff Tangney | Chief Executive Officer | $243,726 |
| Jeffrey A. Tangney | Chief Executive Officer | $243,726 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Paul Jorgensen | Chief Revenue Officer | $8,230,738 |
| Anna Bryson | Chief Financial Officer | $403,211 |
| Jeffrey A. Tangney | Chief Executive Officer | $243,388 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Jeffrey A. Tangney | Chief Executive Officer | $21,312,948 |
| Anna Bryson | Chief Financial Officer | $4,356,867 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Steven L. Zatz, M.D. | President | Appointed | 2026-05-13 |
| Matthew Sonefeldt | Chief Financial Officer | Appointed | 2026-05-13 |
| Siddharth Sitaram | interim principal accounting officer | Appointed | 2026-04-17 |
| Siddharth Sitaram | interim principal financial officer | Appointed | 2026-04-17 |
| Anna Bryson | Chief Financial Officer | Resigned | 2026-04-17 |
| Siddharth Sitaram | interim principal financial officer and interim principal accounting officer | Appointed | 2026-02-05 |
| John Vaughan | Corporate Secretary | Appointed | 2025-08-15 |
| John Vaughan | General Counsel | Appointed | 2025-08-15 |
| Ben Greenberg | SVP of commercial products | Appointed | 2023-05-16 |
| Craig Overpeck | Senior Vice President, Commercial Operations | Appointed | 2023-05-16 |
| Phoebe L. Yang Watkin | Class III director | Appointed | 2022-08-04 |
| Gilbert Kliman, M.D. | director | Resigned | 2022-08-04 |